NASDAQ: SVRARUSSELL2000
Savara Inc.
Healthcare · Biotechnology · Headquartered in Langhorne, US
Price
Loading chart…
Overview
Savara Inc. is a biopharmaceutical firm in the clinical development phase, specializing in therapies for uncommon respiratory conditions. Their primary investigational drug, molgramostim, is an inhaled form of granulocyte-macrophage colony-stimulating factor (GM-CSF). This compound is currently undergoing Phase III trials to address autoimmune pulmonary alveolar proteinosis. The company's main operations are situated in Austin, Texas.
History & business model
This section is waiting to be written.
InvestWiki is community-edited. Contribute a plain-English history of Savara Inc., its business model, key products, and controversies.